[{"id":"1b238410-8dad-4bc2-9f73-b3d0eced958d","acronym":"","url":"https://clinicaltrials.gov/study/NCT06273878","created_at":"2024-02-23T17:27:11.589Z","updated_at":"2024-07-02T16:35:17.792Z","phase":"","brief_title":"From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy","source_id_and_acronym":"NCT06273878","lead_sponsor":"Regina Elena Cancer Institute","biomarkers":" NLRP3","pipe":"","alterations":" ","tags":["NLRP3"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 01/15/2023","start_date":" 01/15/2023","primary_txt":" Primary completion: 01/15/2025","primary_completion_date":" 01/15/2025","study_txt":" Completion: 01/15/2025","study_completion_date":" 01/15/2025","last_update_posted":"2024-02-23"},{"id":"a03d3af5-bc9a-495c-a3cf-cca5e665a5f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT06082362","created_at":"2023-10-14T01:13:16.661Z","updated_at":"2024-07-02T16:35:33.610Z","phase":"","brief_title":"Personalized Signature of Chronic Inflammation and Early Aging Predictive of the Comorbidities in Infertile Men","source_id_and_acronym":"NCT06082362","lead_sponsor":"IRCCS San Raffaele","biomarkers":" CD8 • CD4 • IL18 • IL1B • NLRP3 • CASP1","pipe":"","alterations":" ","tags":["CD8 • CD4 • IL18 • IL1B • NLRP3 • CASP1"],"overall_status":"Recruiting","enrollment":" Enrollment 350","initiation":"Initiation: 06/21/2023","start_date":" 06/21/2023","primary_txt":" Primary completion: 06/20/2024","primary_completion_date":" 06/20/2024","study_txt":" Completion: 06/20/2025","study_completion_date":" 06/20/2025","last_update_posted":"2023-10-13"},{"id":"79ff0d7f-8e12-46e7-a59f-373c976c10bc","acronym":"","url":"https://clinicaltrials.gov/study/NCT05638542","created_at":"2022-12-06T15:57:57.071Z","updated_at":"2024-07-02T16:35:50.646Z","phase":"","brief_title":"Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp","source_id_and_acronym":"NCT05638542","lead_sponsor":"Seoul National University Bundang Hospital","biomarkers":" EGFR • PD-L1 • KRAS • BRAF • TP53 • MSI • MLH1 • MSH6 • MSH2 • PMS2 • RUNX3 • IL1B • NLRP3 • NEUROG1 • CASP1","pipe":" | ","alterations":" PD-L1 expression • TP53 mutation • KRAS mutation • EGFR mutation • MSI-H/dMMR • BRAF mutation • EGFR expression • PMS2 mutation • TP53 expression • PD-L1 mutation","tags":["EGFR • PD-L1 • KRAS • BRAF • TP53 • MSI • MLH1 • MSH6 • MSH2 • PMS2 • RUNX3 • IL1B • NLRP3 • NEUROG1 • CASP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • TP53 mutation • KRAS mutation • EGFR mutation • MSI-H/dMMR • BRAF mutation • EGFR expression • PMS2 mutation • TP53 expression • PD-L1 mutation"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 582","initiation":"Initiation: 03/01/2015","start_date":" 03/01/2015","primary_txt":" Primary completion: 01/30/2021","primary_completion_date":" 01/30/2021","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2023-04-13"},{"id":"e83c17e8-133d-453c-8322-2204032a5fcc","acronym":"CarFlog","url":"https://clinicaltrials.gov/study/NCT04122937","created_at":"2021-01-18T20:08:27.483Z","updated_at":"2024-07-02T16:36:53.224Z","phase":"","brief_title":"Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer.","source_id_and_acronym":"NCT04122937 - CarFlog","lead_sponsor":"University of Pisa","biomarkers":" PD-L1 • BRAF • FGFR1 • CD8 • PD-1 • VEGFA • IL6 • LAG3 • TNFA • CD4 • IL2 • CCL2 • CD68 • TGFB1 • NLRP3","pipe":"","alterations":" ","tags":["PD-L1 • BRAF • FGFR1 • CD8 • PD-1 • VEGFA • IL6 • LAG3 • TNFA • CD4 • IL2 • CCL2 • CD68 • TGFB1 • NLRP3"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"Initiation: 03/01/2017","start_date":" 03/01/2017","primary_txt":" Primary completion: 06/01/2018","primary_completion_date":" 06/01/2018","study_txt":" Completion: 03/30/2019","study_completion_date":" 03/30/2019","last_update_posted":"2019-11-25"}]